Australian Health Authority To Allow Psilocybin And MDMA Assisted Therapy For Depression, PTSD Feb 3, 2023
MAPS Executive Director Predicts MDMA Assisted Therapy Will Be Approved “Sometime Around April-May 2024” Jan 27, 2023
Mydecine Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting MDMA Analogs Jul 19, 2022
Trade To Black Podcast: Numinus CEO Breaks Down B.C. Drug Possession News And Macro Psychedelic Market Jun 5, 2022
Cybin Announces Roster of 28 Expert Faculty and Advisors for its EMBARK Psychedelic Facilitator Training Program Jun 3, 2022
